134 related articles for article (PubMed ID: 19855313)
81. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
[TBL] [Abstract][Full Text] [Related]
82. Rapid high-performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of venlafaxine and O-desmethylvenlafaxine in human plasma and its application in comparative bioavailability study.
Rajasekhar D; Kumar IJ; Venkateswarlu P
Biomed Chromatogr; 2009 Dec; 23(12):1300-7. PubMed ID: 19517423
[TBL] [Abstract][Full Text] [Related]
83. The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.
Unterecker S; Proft F; Riederer P; Lauer M; Deckert J; Pfuhlmann B
Ther Drug Monit; 2014 Apr; 36(2):269-72. PubMed ID: 24365982
[TBL] [Abstract][Full Text] [Related]
84. Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.
Launiainen T; Rasanen I; Vuori E; Ojanperä I
Int J Legal Med; 2011 May; 125(3):349-58. PubMed ID: 20432045
[TBL] [Abstract][Full Text] [Related]
85. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
Murrell MD; Cruz DA; Javors MA; Thompson PM
J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
[TBL] [Abstract][Full Text] [Related]
86. Diazepam and its metabolites in the mothers' and newborns' hair as a biomarker of prenatal exposure.
Senczuk-Przybylowska M; Florek E; Piekoszewski W; Merritt TA; Lechowicz E; Mazela J; Kulza M; Breborowicz GH; Krzyscin M; Markwitz W; Miechowicz I
J Physiol Pharmacol; 2013 Aug; 64(4):499-504. PubMed ID: 24101397
[TBL] [Abstract][Full Text] [Related]
87. Postmortem tissue concentrations of venlafaxine.
Goeringer KE; McIntyre IM; Drummer OH
Forensic Sci Int; 2001 Sep; 121(1-2):70-5. PubMed ID: 11516890
[TBL] [Abstract][Full Text] [Related]
88. Quantification of eight new antidepressants and five of their active metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry.
Castaing N; Titier K; Receveur-Daurel M; Le-Déodic M; Le-bars D; Moore N; Molimard M
J Anal Toxicol; 2007; 31(6):334-41. PubMed ID: 17725879
[TBL] [Abstract][Full Text] [Related]
89. Simultaneous quantitation of venlafaxine and its main metabolite, O-desmethylvenlafaxine, in human saliva by HPLC.
Dziurkowska E; Wesolowski M
J Sep Sci; 2013 Jun; 36(11):1726-33. PubMed ID: 23495235
[TBL] [Abstract][Full Text] [Related]
90. A simple HPLC method for the simultaneous determination of venlafaxine and its major metabolite O-desmethylvenlafaxine in human serum.
Samanidou V; Nazyropoulou C; Kovatsi L
Bioanalysis; 2011 Aug; 3(15):1713-8. PubMed ID: 21827270
[TBL] [Abstract][Full Text] [Related]
91. Hair analysis by LC-MS as evidence of nalbuphine abuse by a nurse.
Klinzig F; Vinner E; Brassart C; Houdain E; Humbert L; Lhermitte M
J Anal Toxicol; 2007; 31(1):62-5. PubMed ID: 17389085
[TBL] [Abstract][Full Text] [Related]
92. Distribution of venlafaxine and O-desmethylvenlafaxine in a fatal case.
Vignali C; Morini L; Chen Y; Stramesi C; Groppi A
Forensic Sci Int; 2014 Sep; 242():e48-e51. PubMed ID: 25086830
[TBL] [Abstract][Full Text] [Related]
93. Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine.
Allen KR
Clin Toxicol (Phila); 2006; 44(2):147-53. PubMed ID: 16615670
[TBL] [Abstract][Full Text] [Related]
94. Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism.
Castanares-Zapatero D; Gillard N; Capron A; Haufroid V; Hantson P
Forensic Sci Int; 2016 Sep; 266():e48-e51. PubMed ID: 27328779
[TBL] [Abstract][Full Text] [Related]
95. Enantioselective analysis of venlafaxine and its active metabolites: A review on the separation methodologies.
Hancu G; Lupu D; Milan A; Budău M; Barabás-Hajdu E
Biomed Chromatogr; 2021 Jan; 35(1):e4874. PubMed ID: 32367587
[TBL] [Abstract][Full Text] [Related]
96. Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjects.
Taft DR; Iyer GR; Behar L; DiGregorio RV
Drug Metab Dispos; 1997 Oct; 25(10):1215-8. PubMed ID: 9321527
[TBL] [Abstract][Full Text] [Related]
97. Assessment of in-utero venlafaxine induced, ROS-mediated, apoptotic neurodegeneration in fetal neocortex and neurobehavioral sequelae in rat offspring.
Singh M; Singh KP; Shukla S; Dikshit M
Int J Dev Neurosci; 2015 Feb; 40():60-9. PubMed ID: 25450524
[TBL] [Abstract][Full Text] [Related]
98. Development and validation of a flow-injection assay for dissolution studies of the anti-depressant drug venlafaxine.
Tzanavaras PD; Verdoukas A; Themelis DG
Anal Sci; 2005 Dec; 21(12):1515-8. PubMed ID: 16379397
[TBL] [Abstract][Full Text] [Related]
99. Infant with in utero ketamine exposure: quantitative measurement of residual dosage in hair.
Su PH; Chang YZ; Chen JY
Pediatr Neonatol; 2010 Oct; 51(5):279-84. PubMed ID: 20951358
[TBL] [Abstract][Full Text] [Related]
100. Elucidating venlafaxine metabolism in the Mediterranean mussel (Mytilus galloprovincialis) through combined targeted and non-targeted approaches.
Ariza-Castro N; Courant F; Dumas T; Marion B; Fenet H; Gomez E
Sci Total Environ; 2021 Jul; 779():146387. PubMed ID: 34030260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
